| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899345 | Diabetes Research and Clinical Practice | 2015 | 8 Pages |
Abstract
In patients with T2D and overt nephropathy, the observed correlation of low eGFR with high HbA1c was not predicted by eGFR. Our data rather underscore a different use of antidiabetic treatments in patients with advanced renal dysfunction, and the difficulty to improve glycemic control in patients with long standing insulin therapy.
Keywords
HBPMEntredErythropoiesis stimulating agentRASCRFESAMDRDOADABPMARBHbA1cEGFRAngiotensin converting enzyme inhibitorsmodification of diet in renal diseasestandard deviationchronic kidney diseaseType 2 diabetesRenin angiotensin systembody mass indexBMIOral antidiabetic agentsBlood pressureangiotensin II receptor blockersACEI یا angiotensin convert enzyme inhibitorestimated glomerular filtration rateCKDGlomerular filtration ratehome blood pressure monitoringambulatory blood pressure monitoringOvert nephropathyGlycated hemoglobinGlycemic control
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Dominique Joly, Gabriel Choukroun, Christian Combe, Bertrand Dussol, Jean-Pierre Fauvel, Jean-Michel Halimi, Stéphane Quéré, Béatrice Fiquet,